HOUSTON–(BUSINESS WIRE)–The Kidney Cancer Association (KCA) is pleased to announce its Board of
Directors recently approved $1.3 million in new grant funding to advance
early detection and new treatments for kidney cancer. The application
process opens on April 17 and closes on May 20. Award winners will be
announced in the Fall of 2019.
Six grants are divided among two distinct awards – the Advanced
Discovery Awards (ADA), two $500,000 grants for established
investigators, and four $75,000 Young Investigator Awards (YIA).
The purpose of establishing the new ADA is to promote the collaboration
between a clinician including a urologic oncologist, medical oncologist
or radiation oncologist and a Ph.D., to propose new research that will
make an immediate impact in the field of kidney cancer. Research may
include biomarker development, development of novel therapeutic targets,
correlative studies associated with ongoing or completed clinical
trials, or assays that promote the early detection of kidney cancer.
The YIA seeks to encourage promising researchers in the areas of urology
and clinical oncology who are planning to pursue an investigative career
in kidney cancer. To qualify, applicants must have achieved a
post-graduate degree or doctoral degree and currently be in the last two
years of their final subspecialty training at an academic medical
institution (a single entity medical school and university hospital) at
the time of their application. The KCA has increased the amounts of the
YIA from $50,000 to $75,000, and increased the number of grants from two
to four to encourage more of these rising stars in this field.
All grant proposals will be evaluated through the Letter of Intent (LOI)
Process. An independent panel of reviewers, who are recognized experts
in the field, will conduct a blinded, scored review of all applications
Visit the KCA website at https://www.kidneycancer.org
for additional information and application guidelines on the ADA and YIA.
Jennie Roberts, Elmore Public Relations